H. Lundbeck ASFRA:LDBA +3.13%81 OCF Yield % is 13.11 as of Jul. 04, 2026, which is 1% above its 10-year median of 13.04. GuruFocus rates FRA:LDBA with a GF Score™ of 81/100 and a GF Value™ of €6.31 (Fairly Valued). The stock has 4 warning signs investors should review. Among 1,007 Drug Manufacturers companies, H. Lundbeck AS ranks better than 86.4% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
H. Lundbeck AS OCF Yield % Related Terms
H. Lundbeck AS OCF Yield % Historical Data
* Premium members only.
The historical data trend for H. Lundbeck AS's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:LDBA vs ZTS, UTHR, VTRS: OCF Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, H. Lundbeck AS's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
H. Lundbeck AS OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, H. Lundbeck AS's OCF Yield % distribution charts can be found below:
* The bar in red indicates where H. Lundbeck AS's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
H. Lundbeck AS (FRA:LDBA) has a OCF Yield % of 13.11 as of Jul. 04, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on H. Lundbeck AS and its competitors. This is near median its historical median of 13.04. Over the past decade, H. Lundbeck AS's OCF Yield % has ranged from 5.85 to 17.23. According to the industry distribution chart, H. Lundbeck AS ranks #137 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 13.6%.
Is H. Lundbeck AS's OCF Yield % too high?
H. Lundbeck AS's current OCF Yield % of 13.11 is near median its 10-year median of 13.04. Over the past 10 years, this metric has ranged from a low of 5.85 to a high of 17.23. The Drug Manufacturers industry median OCF Yield % is 3.43. H. Lundbeck AS's value of 13.11 is 282.2% above this industry median. Based on the distribution chart, H. Lundbeck AS ranks #137 out of 1007 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, H. Lundbeck AS has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does H. Lundbeck AS's OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, H. Lundbeck AS ranks #137 out of 1007 companies for OCF Yield %. This places H. Lundbeck AS in the top 14% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 3.43. H. Lundbeck AS's value of 13.11 is 282.2% above this benchmark. Historically, H. Lundbeck AS's own OCF Yield % has ranged from 5.85 to 17.23 over the past decade. While the company's 10-year median is 13.04 vs. the industry median of 3.43, H. Lundbeck AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.43, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. H. Lundbeck AS's current OCF Yield % of 13.11 is 282.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on H. Lundbeck AS and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. H. Lundbeck AS's current OCF Yield % is 13.11, which is near median its own 10-year median of 13.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H. Lundbeck AS stock overvalued right now?
Based on GuruFocus' analysis, H. Lundbeck AS (FRA:LDBA) is currently considered Fairly Valued. The stock's GF Value™ is €6.31, compared to a current price of €5.93 — trading 6.1% below its estimated fair value. The current OCF Yield % is 13.11, which is near median its 10-year median of 13.04 and 282.2% above the Drug Manufacturers industry median of 3.43. H. Lundbeck AS's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For H. Lundbeck AS (FRA:LDBA), the current OCF Yield % is 13.11 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is H. Lundbeck AS (FRA:LDBA) Overvalued in 2026?
Based on GuruFocus' analysis, H. Lundbeck AS stock appears to be undervalued.
The current stock price of €5.93 is trading 6.1% below its estimated GF Value™ of €6.31.
GuruFocus considers H. Lundbeck AS to be Fairly Valued.
Key valuation signals for FRA:LDBA:
OCF Yield %: 13.11 (near median its 10-year median of 13.04)
GF Value™: €6.31 vs. price of €5.93 (6.1% below fair value)
Industry Position: 282.2% above the Drug Manufacturers median (#137 of 1007)
No single metric tells the full story. See the FRA:LDBA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.
81GF Score
Get the complete analysis for FRA:LDBA
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:LDBA has been successfully added to your 
